Stock analysts at The Goldman Sachs Group started coverage on shares of Aviva (LON:AV – Get Free Report) in a research note issued to investors on Wednesday, MarketBeat Ratings reports. The brokerage set a “buy” rating on the stock.
Other research analysts have also issued reports about the stock. Jefferies Financial Group raised their target price on shares of Aviva from GBX 525 ($6.94) to GBX 550 ($7.27) and gave the stock a “buy” rating in a research note on Monday, September 9th. JPMorgan Chase & Co. reissued a “neutral” rating and set a GBX 545 ($7.20) price objective on shares of Aviva in a research note on Friday, July 5th. Three research analysts have rated the stock with a hold rating and four have assigned a buy rating to the company’s stock. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average target price of GBX 524.80 ($6.93).
Aviva Stock Performance
Insider Activity
In other Aviva news, insider Pippa Lambert acquired 1,003 shares of the company’s stock in a transaction that occurred on Friday, June 28th. The stock was purchased at an average price of GBX 482 ($6.37) per share, for a total transaction of £4,834.46 ($6,386.34). In related news, insider Pippa Lambert acquired 1,003 shares of the firm’s stock in a transaction dated Friday, June 28th. The stock was acquired at an average price of GBX 482 ($6.37) per share, for a total transaction of £4,834.46 ($6,386.34). Also, insider Thomas Neil purchased 100,000 shares of the stock in a transaction on Monday, June 24th. The shares were purchased at an average price of GBX 484 ($6.39) per share, with a total value of £484,000 ($639,365.92). Over the last ninety days, insiders bought 107,253 shares of company stock valued at $52,002,196. 0.17% of the stock is currently owned by corporate insiders.
Aviva Company Profile
Aviva plc provides various insurance, retirement, investment, and savings products in the United Kingdom, Ireland, Canada, and internationally. The company offers life insurance, long-term health and accident insurance, savings, pension, and annuity products, as well as pension fund business and lifetime mortgage products.
See Also
- Five stocks we like better than Aviva
- Using the MarketBeat Stock Split Calculator
- Edgewise Therapeutics Soars 50%: Key Reasons Behind the Surge
- How to Invest in Small Cap Stocks
- How the Fed’s Rate Cut Could Supercharge These 3 ETFs
- Investing In Automotive Stocks
- Microsoft Stock: 3 Reasons It’s Ready to Crush Q4
Receive News & Ratings for Aviva Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aviva and related companies with MarketBeat.com's FREE daily email newsletter.